A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆
N
Shared by NobleBlocks on Mar 1, 2021 • 12:00 AM UTC
Authors:
S.H. Park
,
D.H. Lim
,
T.S. Sohn
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆ | NobleBlocks
